A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.

Evans, C; Devadatta, S; Fox, W; Gangadharam, P R; Menon, N K; Ramakrishnan, C V; Sivasubramanian, S; Somasundaram, P R; Stott, H; Velu, S

Evans, C; Devadatta, S; Fox, W; Gangadharam, P R; Menon, N K; Ramakrishnan, C V; Sivasubramanian, S; Somasundaram, P R; Stott, H; Velu, S.

Bull World Health Organ ; 41(1): 1-16, 1969.

Article in En | MEDLINE | ID: mdl-5309083

Subject(s)

Aminosalicylic Acids/therapeutic use; Isoniazid/therapeutic use; Tuberculosis, Pulmonary/drug therapy; Aminosalicylic Acids/administration & dosage; Antitubercular Agents/therapeutic use; Drug Resistance, Microbial; Follow-Up Studies; Home Care Services; Humans; India; Isoniazid/administration & dosage

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary / Aminosalicylic Acids / Isoniazid Type of study: Observational_studies / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Bull World Health Organ Year: 1969 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google